Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

HIV Infection

Free Subscription 24.02.2025 3 AIDS 2 AIDS Res Hum Retroviruses 1 Antimicrob Agents Chemother 1 Antivir Ther 1 BMC Immunol 1 BMJ 3 Clin Infect Dis 3 HIV Med 9 J Acquir Immune Defic Syndr 1 J Infect Dis 3 J Med Virol 1 Nature 1 PLoS Comput Biol 3 PLoS One 1 Proc Natl Acad Sci U S A 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. CHALOUNI M, Van Santen DK, Berenguer J, Jarrin I, et al
   Time to direct-acting antivirals initiation and liver-related events in people with HIV and Hepatitis C virus.
   AIDS. 2025 Feb 19. doi: 10.1097/QAD.0000000000004161.
   PubMed         Abstract available
   
   
2. LI W, Egler A, Oyungu E, Yang Z, et al
   Pro- and anti-inflammatory immune biomarkers as predictors of neurodevelopment in young children exposed to HIV.
   AIDS. 2025 Feb 19. doi: 10.1097/QAD.0000000000004162.
   PubMed         Abstract available
   
   
3. NUHN MM, Bosman K, Huisman T, Staring WHA, et al
   Selective decline of intact HIV reservoirs during the first decade of ART followed by stabilization in memory T cell subsets.
   AIDS. 2025 Feb 17. doi: 10.1097/QAD.0000000000004160.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

4. ZHANG L, Feng Y, Shen K, Wang L, et al
   Near-Full-Length Genomic Characterization of Two Novel HIV-1 Unique Recombinants (CRF01_AE/CRF07_BC) and (CRF01_AE/CRF68_01B) in Shijiazhuang, Hebei Province, China.
   AIDS Res Hum Retroviruses. 2025 Feb 18. doi: 10.1089/aid.2024.0114.
   PubMed         Abstract available
   
   
5. SHI Y, Zhang T, Yao H, Wang H, et al
   Molecular Network Characteristics and Drug Resistance Analysis Among Newly Diagnosed Persons Living with HIV-1 in Hefei, China (2017-2022).
   AIDS Res Hum Retroviruses. 2025 Feb 18. doi: 10.1089/aid.2024.0093.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

6. LAZZARO A, Recchia GE, Alessi F, Santinelli L, et al
   Efficacy, safety, and anti-inflammatory properties of the switch to a doravirine-based regimen among antiretroviral-experienced elderly people living with HIV-1: the DORAGE cohort.
   Antimicrob Agents Chemother. 2025 Feb 18:e0081524. doi: 10.1128/aac.00815.
   PubMed         Abstract available
   
   

   
   Antivir Ther

7. PICKERING RT, Asundi A, Olson A, Soden K, et al
   Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir.
   Antivir Ther. 2025;30:13596535251314571.
   PubMed         Abstract available
   
   

   
   BMC Immunol

8. CHAWANA TD, Walsh SR, Stranix-Chibanda L, Chirenje ZM, et al
   Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV.
   BMC Immunol. 2025;26:8.
   PubMed         Abstract available
   
   

   
   BMJ

9. WANG X, Martin G, Sadeghirad B, Chang Y, et al
   Common interventional procedures for chronic non-cancer spine pain: a systematic review and network meta-analysis of randomised trials.
   BMJ. 2025;388:e079971.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

10. LUETKEMEYER AF, Chew KW, Lacey S, Hughes MD, et al
    Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.
    Clin Infect Dis. 2025 Feb 17:ciaf029. doi: 10.1093.
    PubMed         Abstract available
    
    
11. TZELIOS CA, Malatesta S, Carney T, White LF, et al
    Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis.
    Clin Infect Dis. 2025 Feb 20:ciae642. doi: 10.1093.
    PubMed         Abstract available
    
    
12. OKUMURA N, Morino E, Nomoto H, Yanagi M, et al
    LC16m8 for Pre-exposure Prophylaxis against Mpox in a High-Risk Population: An Open-Label Randomized Trial.
    Clin Infect Dis. 2025 Feb 21:ciaf074. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

13. MEDINA N, Alastruey-Izquierdo A, Bonilla O, Mercado D, et al
    Patients re-engaging with HIV care in Guatemala: Prioritizing CD4 counting and screening for histoplasmosis and tuberculosis.
    HIV Med. 2025 Feb 17. doi: 10.1111/hiv.70000.
    PubMed         Abstract available
    
    
14. AKASHANAND, Khatib MN, Serhan HA, Jena D, et al
    Spatial and temporal trends in HIV/AIDS burden among South Asian countries from 1990 to 2021: A systematic examination of the Global Burden of Disease study 2021.
    HIV Med. 2025 Feb 19. doi: 10.1111/hiv.70003.
    PubMed         Abstract available
    
    
15. YU S, MacGibbon J, Bavinton B, Smith AKJ, et al
    Associations between country of birth, migration status and engagement in HIV care among gay and bisexual men living with HIV in Australia, 2019-2022.
    HIV Med. 2025 Feb 19. doi: 10.1111/hiv.13769.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

16. ZHU X, Patel EU, Berry SA, Grabowski MK, et al
    Brief Report: Trends in Hospital Readmissions Among Adults With and Without HIV in the United States, 2010-2020.
    J Acquir Immune Defic Syndr. 2025;98:334-339.
    PubMed         Abstract available
    
    
17. THEODORE DA, Neradilek M, Gillespie K, Edupuganti S, et al
    Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085.
    J Acquir Immune Defic Syndr. 2025;98:340-345.
    PubMed         Abstract available
    
    
18. GRAVETT RM, Long DM, Biello KB, Mayer KH, et al
    Preferences for monthly oral PrEP over other PrEP modalities among a national sample of gay, bisexual, and other men who have sex with men in the United States.
    J Acquir Immune Defic Syndr. 2025 Feb 20. doi: 10.1097/QAI.0000000000003651.
    PubMed         Abstract available
    
    
19. YOUNG J, Wang S, Sacks-Davis R, Stewart A, et al
    Liver fibrosis regression in people living with HIV after successful treatment for hepatitis C.
    J Acquir Immune Defic Syndr. 2025 Feb 20. doi: 10.1097/QAI.0000000000003646.
    PubMed         Abstract available
    
    
20. LANG R, Coburn SB, Gill MJ, Grossman J, et al
    The Association of Anemia on Non-AIDS Defining Cancer and Subsequent Survival among People with HIV following Antiretroviral Initiation.
    J Acquir Immune Defic Syndr. 2025 Feb 20. doi: 10.1097/QAI.0000000000003647.
    PubMed         Abstract available
    
    
21. GATHE JC, Dejesus E, Ramgopal MN, Rolle CP, et al
    Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): a Randomized, Double-Blind, Placebo-Controlled Trial.
    J Acquir Immune Defic Syndr. 2025 Feb 20. doi: 10.1097/QAI.0000000000003648.
    PubMed         Abstract available
    
    
22. SHILABYE PS, Scheuermaier K, Vos-Seda AG, Barth RE, et al
    THE ASSOCIATION BETWEEN HIV-RELATED STIGMA, ART ADHERENCE AND CARDIOVASCULAR DISEASE RISK IN PEOPLE LIVING WITH HIV.
    J Acquir Immune Defic Syndr. 2025 Feb 20. doi: 10.1097/QAI.0000000000003653.
    PubMed         Abstract available
    
    
23. WANG RJ, Kunisaki KM, Morris A, Drummond MB, et al
    Brief Report: The Implications of Removing Race From Interpretation of Pulmonary Function Among Persons With or Without HIV.
    J Acquir Immune Defic Syndr. 2025;98:395-400.
    PubMed         Abstract available
    
    
24. TARAMASSO L, Rossotti R, Tavelli A, Santoro MM, et al
    Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort.
    J Acquir Immune Defic Syndr. 2025;98:352-356.
    PubMed         Abstract available
    
    

    
    J Infect Dis

25. CHOW FC, Kafeero P, Muhumuza P, Nakimbugwe M, et al
    Safety and Tolerability of a Short Course of Linezolid for the Treatment of Predominantly Moderate to Severe Tuberculous Meningitis in Adults with HIV.
    J Infect Dis. 2025 Feb 17:jiaf089. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

26. LU Z, Dong B, Yao P, Huang Y, et al
    Characteristics of Human Papillomavirus Prevalence and Infection Patterns Among Women Aged 35-65 in Fujian Province, China: A Nine-Year Retrospective Observational Study.
    J Med Virol. 2025;97:e70238.
    PubMed         Abstract available
    
    
27. HOTA M, Wondeu ALD, Abakar MF, Dezoumbe K, et al
    Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in N'Djamena: Insights Into Chad's COVID-19 Epicenter.
    J Med Virol. 2025;97:e70234.
    PubMed         Abstract available
    
    
28. LI K, Luo L, Ji Y, Zhang Q, et al
    Urgent Focus on the Surgical Risks of People Living With HIV: A Systematic Review and Meta-Analysis.
    J Med Virol. 2025;97:e70260.
    PubMed         Abstract available
    
    

    
    Nature

29. NADDAF M
    AI tool diagnoses diabetes, HIV and COVID from a blood sample.
    Nature. 2025 Feb 20. doi: 10.1038/d41586-025-00528.
    PubMed        
    
    

    
    PLoS Comput Biol

30. BANHOLZER N, Middelkoop K, Leukes J, Weingartner E, et al
    Estimating Mycobacterium tuberculosis transmission in a South African clinic: Spatiotemporal model based on person movements.
    PLoS Comput Biol. 2025;21:e1012823.
    PubMed         Abstract available
    
    

    
    PLoS One

31. ADU-GYAMFI R, Addo SA, Baddoo NA, Kenu E, et al
    HIV retesting prevalence among clients accessing anti-retroviral therapy and HIV testing services in Ghana.
    PLoS One. 2025;20:e0316915.
    PubMed         Abstract available
    
    
32. LUIZ N, Muleia R, Abecasis A, Banze A, et al
    Unveiling triple vulnerability among Mozambican female sex workers-Stigma, physical violence and sexual violence.
    PLoS One. 2025;20:e0312550.
    PubMed         Abstract available
    
    
33. KITENGE MK, Fatti G, Eshun-Wilson I, Nyasulu PS, et al
    Persistent advanced HIV disease in rural KwaZulu-Natal, South Africa: Trends, characteristics, and the urgent need for targeted interventions.
    PLoS One. 2025;20:e0317674.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

34. GAO Y, Barton JP
    A binary trait model reveals the fitness effects of HIV-1 escape from T cell responses.
    Proc Natl Acad Sci U S A. 2025;122:e2405379122.
    PubMed         Abstract available
    
    

    
    Science

35. ZASLAVSKY ME, Craig E, Michuda JK, Sehgal N, et al
    Disease diagnostics using machine learning of B cell and T cell receptor sequences.
    Science. 2025;387:eadp2407.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.